Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients

Table 2

Correlation between the serum calprotectin level and other findings of the study population.

Characteristics	All (87)		Control (n = 38)		Hypertensive (n = 49)
	Age (years)	0.161	0.136	0.143	0.393	0.241	0.096
SBP (mmHg)	−0.411	0.001	0.126	0.450	−0.096	0.512
DBP (mmHg)	−0.377	0.001	0.153	0.359	−0.01	0.945
Glucose (mg/dL)	−0.037	0.734	0.076	0.649	−0.140	0.336
Creatinine (mg/dL)	−0.204	0.059	0.104	0.536	0.026	0.860
eGFR (mL/dk/1.73 m^2)	0.092	0.396	−0.057	0.733	−0.032	0.826
Uric acid (mg/dL)	−0.370	0.001	−0.342	0.038	−0.190	0.190
Sodium (mEq/L)	−0.131	0.226	−0.035	0.834	−0.145	0.321
Potassium (mEq/L)	0.141	0.194	0.124	0.459	0.276	0.055
Albumin (g/dL)	0.039	0.739	0.332	0.105	0.064	0.662
Calcium (mg/dL)	−0.293	0.009	0.059	0.750	−0.279	0.057
CRP (mg/dL)	−0.196	0.07	−0.123	0.470	−0.087	0.550

SBP: systolic blood pressure; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate (as calculated using the Chronic Kidney Disease Epidemiology Collaboration); CRP: C-reactive protein. value <0.05 was significant.